Equity Capital Markets

Company · CIK 1889109

BELITE BIO, INC

CIK1889109 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inE9
Business addressCA
ListedBLTE (Nasdaq)
First annual or quarterly report2023-03-31

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-272125
ShelfEffective
 2023-05-222024-04-296
333-271549
ShelfEffective
 2023-05-012023-05-092
333-264134
IPOFinal prospectus
 2022-04-052022-04-296

Filings

20
FiledFilingRegistrationAccession
2025-12-02424B5Shelf takedown 333-2845210001104659-25-117702
2025-12-01424B5Shelf takedown 333-2845210001104659-25-117377
2025-08-08424B5Shelf takedown 333-2845210001104659-25-075508
2025-02-07424B5Shelf takedown 333-2845210001104659-25-010252
2024-04-29424B5Shelf takedown 333-2721250001104659-24-053797
2023-06-16424B5Shelf takedown 333-2721250001104659-23-072285
2023-06-01424B5Shelf takedown 333-2721250001104659-23-067022
2023-05-30EFFECTDeclared effective 333-2721259999999995-23-001572
2023-05-30424B5Shelf takedown 333-2721250001104659-23-065989
2023-05-22F-3Shelf registered 333-2721250001104659-23-063213
2023-05-09EFFECTDeclared effective 333-2715499999999995-23-001356
2023-05-01F-3Shelf registered 333-2715490001104659-23-054422
2022-04-29424B4Final prospectus 333-2641340001104659-22-053424
2022-04-28EFFECTDeclared effective 333-2643959999999995-22-001147
2022-04-28EFFECTDeclared effective 333-2641349999999995-22-001140
2022-04-27F-1/AAmendment 333-2641340001104659-22-050961
2022-04-22F-1/AAmendment 333-2641340001104659-22-048906
2022-04-20F-1/AAmendment 333-2641340001104659-22-047865
2022-04-05F-1Registration filed 333-2641340001104659-22-042710
2021-12-01DRSDraft made public 377-057450001104659-21-145314

All filings of this company · CSV